Subscribe Now Subscribe Today
Research Article
 

Plasma Lipid Profile in Sickle Cell Disease Patients in Owerri, Nigeria



J.K. Nnodim, A.U. Opara, H.U. Nwanjo and O.A. Ibeaja
 
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail
ABSTRACT

This study was done to determine the plasma lipid profile in sickle cell anaemia patients. Sixty eight sickle cell anemia (HbSS) patients aged 15-35 years were used for the study. A total of seventy healthy volunteers with HbAA genotype aged 15-35 years were used as control. The plasma cholesterol (119.7±18.4 mg/dl) in sickle cell anemia were significantly decreased (p<0.05) when compared with the control (171.4±21.2 mg/dl). Also the plasma high density lipoprotein cholesterol (HDL-C) and low density lipoprotein cholesterol in sickle cell anaemia (40.3±10.5 mg/dl and 51.3±2.1 mg/dl) were significantly decreased (p<0.05) when compared with the control (67.9±14.4 mg/dl and 81.7±2.7 mg/dl). There is no significant variation in the mean level of triglyceride in sickle cell disease when compared with the control. This result shows that sickle cell disease patients are not prone to coronary heart disease.

Services
Related Articles in ASCI
Similar Articles in this Journal
Search in Google Scholar
View Citation
Report Citation

 
  How to cite this article:

J.K. Nnodim, A.U. Opara, H.U. Nwanjo and O.A. Ibeaja, 2012. Plasma Lipid Profile in Sickle Cell Disease Patients in Owerri, Nigeria. Pakistan Journal of Nutrition, 11: 64-65.

DOI: 10.3923/pjn.2012.64.65

URL: https://scialert.net/abstract/?doi=pjn.2012.64.65

REFERENCES
1:  Cheesbrough, M., 2000. District laboratory practices in tropical countries. Part 2 Cambrige low price Edn., Cambrige University Press, USA, pp: 207-266.

2:  Dunlop, R.J. and K.C. Benneth, 2006. Pain management for sickle cell disease. Cochrane Database Syst. Rev., 19: 246-248.

3:  Girot, R., 2005. Current development in sickle cell disease. Rev. Med. Brux, 26: 13-22.

4:  Hashmi, J.A. and A. Nishat, 1982. Hypolipidaemia in anaemia. Am. Heart J., 78: 840-841.

5:  Hoffbrand, V.A., M.S. Lewis and E.G.O. Tuddenham, 1999. Postgraduate Haematology. 4th Edn., Butterworth-Heinemann, UK., pp: 91-110.

6:  Luzzato, L., 1981. Sickle cell anaemia in tropical Africa. Clin. Haematol., 3: 575-577.

7:  Saha, N. and A.P. Samuel, 1982. Sickle cell gene and liver function in a sudanese population. Acta Haemat, 68: 65-67.

8:  Switzer, R.A., D.C. Hess, F.T. Nichols and R.J. Adams, 2006. Pathophysiology and treatment of stroke in sickle cell disease. Lancet Neurol, 6: 501-512.

9:  Tietz, W., 1976. Fundmentals of clinical chemistry. W.B. Saunders Company, Britain.

10:  Ugonabo, M.C., I.C. Onwuamaeze, E.N. Okafor and A.C. Ezeoke, 2007. Plasma cholesterol of sickle cell anaemia patients in Enugu Nigeria. Bio. Res., 5: 241-243.

11:  Uwakwe, A.A., C. Onwuegbuke and N.M. Nwinuka, 2002. Effect of caffeine on the polymerization of HBS and sickling rate, osmotic fragility of HBS and sickling rate, osmotic fragility of HBS erythrocytes. Nig. J. Biochem. Mol. Biol., 1: 27-32.

©  2020 Science Alert. All Rights Reserved